These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26725672)

  • 21. Trends in the medication reviews of community pharmacies in Japan: a nationwide retrospective study.
    Koyama T; Onoue H; Ohshima A; Tanaka Y; Tatebe Y; Zamami Y; Shinomiya K; Kitamura Y
    Int J Clin Pharm; 2018 Feb; 40(1):101-108. PubMed ID: 29189975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The expected role of community pharmacist in society].
    Hayashi S
    Yakugaku Zasshi; 2003 Mar; 123(3):163-71. PubMed ID: 12693017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Education of pharmacists to enable a connection between physicians and persons unaware of their mental illness].
    Kawamura K
    Yakugaku Zasshi; 2013; 133(6):631-43. PubMed ID: 23728091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medication review and patient counselling at discharge from the hospital by community pharmacists.
    Hugtenburg JG; Borgsteede SD; Beckeringh JJ
    Pharm World Sci; 2009 Dec; 31(6):630-7. PubMed ID: 19649720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community Pharmacy Practice Barriers in Preventing Drug Misuse, Divergence and Overdose: A Focus Group Study.
    Leong C; Sareen J; Enns MW; Bolton J; Alessi-Severini S
    Healthc Q; 2015; 18(3):28-33. PubMed ID: 26718251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoting consistent use of prescription drug monitoring programs (PDMP) in outpatient pharmacies: Removing administrative barriers and increasing awareness of Rx drug abuse.
    Norwood CW; Wright ER
    Res Social Adm Pharm; 2016; 12(3):509-14. PubMed ID: 26329535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of pharmacist counseling to enhance the accessibility of naloxone nasal spray to patients in a community pharmacy setting.
    Napoli K; Grant M; Remines J; Nadpara P; Goode JR
    J Am Pharm Assoc (2003); 2021; 61(4S):S127-S134. PubMed ID: 33441280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns.
    Nkansah N; Mostovetsky O; Yu C; Chheng T; Beney J; Bond CM; Bero L
    Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD000336. PubMed ID: 20614422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the factors influencing the quality of "Health Support Pharmacy" services in Japan: Perspectives of community pharmacists.
    Sato N; Fujita K; Kushida K; Chen TF
    Res Social Adm Pharm; 2020 Dec; 16(12):1686-1693. PubMed ID: 32147461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stronger Boxed Warning for Benzodiazepines.
    Aschenbrenner DS
    Am J Nurs; 2021 Mar; 121(3):22-23. PubMed ID: 33625005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Community Pharmacists' Perspectives on Dispensing Medications With the Potential for Misuse, Diversion, and Intentional Overdose: Results of a Province-Wide Survey of Community Pharmacists in Canada.
    Leong C; Alessi-Severini S; Sareen J; Enns MW; Bolton J
    Subst Use Misuse; 2016 Nov; 51(13):1724-30. PubMed ID: 27487323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combating the prescription painkiller epidemic: a national prescription drug reporting program.
    Shepherd J
    Am J Law Med; 2014; 40(1):85-112. PubMed ID: 24844043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Self-medication Activities in a Community Pharmacy for Student Pharmacist Training].
    Sakaguchi M
    Yakugaku Zasshi; 2016; 136(7):951-4. PubMed ID: 27374956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community pharmacy practice in China: past, present and future.
    Fang Y; Yang S; Zhou S; Jiang M; Liu J
    Int J Clin Pharm; 2013 Aug; 35(4):520-8. PubMed ID: 23661172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knowledge and practices of community pharmacists towards non-prescription dispensing of antibiotics in Northern Nigeria.
    Abubakar U; Tangiisuran B
    Int J Clin Pharm; 2020 Apr; 42(2):756-764. PubMed ID: 32270378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do no harm: the role of community pharmacists in regulating public access to prescription drugs in Saudi Arabia.
    Bahnassi A
    Int J Pharm Pract; 2016 Apr; 24(2):142-5. PubMed ID: 26383607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current Status of Community Pharmacies: Expectations as a Health Information Hub, the Enforcement of Revised Pharmaceutical and Medical Device Act, and a New Role as Stakeholders].
    Saito M
    Yakugaku Zasshi; 2016; 136(2):245-9. PubMed ID: 26831801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appropriateness of ambulatory prescriptions in Taiwan: translating claims data into initiatives.
    Ho YF; Hsieh LL; Lu WC; Hu FC; Hale KM; Lee SJ; Lin FJ
    Int J Clin Pharm; 2012 Feb; 34(1):72-80. PubMed ID: 22138781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.